Yixintang Pharmaceutical (SZ:002727)2024-05-17 12:43Group 1: Investor Relations Activity Overview - The activity involved 46 institutional investors, including major firms like CITIC Securities and Huatai Securities [1] - The event took place from May 16 to May 17, 2024, at the headquarters of Yixintang Pharmaceutical Group [1] - Key personnel included Mr. Li Zhenghong, Vice President and Secretary of the Board, and Ms. Yin Guanxiang, Securities Affairs Representative [1] Group 2: Content of the Investor Relations Activity - The main topics discussed included the 2023 annual report and the Q1 2024 performance exchange meeting [1] - The event was categorized as a specific audience survey and included a company visit [1] - Additional materials provided included records of the investor survey meeting [1]